Lonicera caerulea L. berry
polyphenols (LCBP) are considered as major components for bioactivity. This study aimed to clarify the molecular mechanisms by monitoring inflammatory and
antioxidant mediator actions in
lipopolysaccharide (LPS)-induced mouse paw
edema and macrophage cell model. LCBP significantly attenuated LPS-induced paw
edema (3.0 ± 0.1 to 2.8 ± 0.1 mm, P < 0.05) and reduced (P < 0.05) serum levels of
monocyte chemotactic protein-1 (MCP-1, 100.9 ± 2.3 to 58.3 ± 14.5 ng/mL),
interleukin (IL)-10 (1596.1 ± 424.3 to 709.7 ± 65.7 pg/mL),
macrophage inflammatory protein (MIP)-1α (1761.9 ± 208.3 to 1369.1 ± 56.4 pg/mL),
IL-6 (1262.8 ± 71.7 to 499.0 ± 67.1 pg/mL),
IL-4 (93.3 ± 25.7 to 50.7 ± 12.5 pg/mL), IL-12(p-70) (580.4 ± 132.0 to 315.2 ± 35.1 pg/mL), and
tumor necrosis factor-α (TNF-α, 2045.5 ± 264.9 to 1270.7 ± 158.6 pg/mL). Cell signaling analysis revealed that LCBP inhibited
transforming growth factor β activated kinase-1 (TAK1)-mediated
mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB) pathways, and enhanced the expression of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and
manganese-dependent
superoxide dismutase (MnSOD) in earlier response. Moreover,
cyanidin 3-glucoside (C3G) and (-)-
epicatechin (EC), two major components of LCBP, directly bound to TAK1. These data demonstrated that LCBP might inhibit LPS-induced
inflammation by modulating both inflammatory and
antioxidant mediators.